CClinicalTrials.gg
CompletedNCT01681719EVAWIEUpdated Sep 10, 2012

Ergospirometric Values and WBV in Elderly

An interventional study of WBV and Resistance and resistance & sham WBV in Aging, sponsored by Maíra F Pessoa. Completed at 1 site in Brazil. Open to participants aged 60 Years to 74 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-09-10.

Sponsored by Maíra F Pessoa · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
60 Years to 74 Years
Sex
All
01

Study summary

this study aims evaluate the ergospirometric values after 03 months of training with WBV in elderly health people. The hypothesis is increases of ergospirometric values.

02

Conditions studied

  • Aging

Keywords

  • VO2
  • VCO2
  • VE/VO2
  • heart rate
03

In context

Lead sponsor

Maíra F Pessoa is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 74 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • aged 60-74 years,
  • Sedentary or Moderate A in accord with IPAQ short form (International Physical Activity Questionnaire) and those without disease.
  • furthermore, the subjects should reach the ventilatory threshold 1, considered after meeting two of the following events:
  • respiratory quotient (R) increases (R ≥1,1);
  • loss of linearity between the pulmonary ventilation curve (VE) and oxygen consumption (VO2), plateau of VO2 or plateau of heart rate (HR) and increases of end-tidal PO2 (Pet O2)

Exclusion criteria

Exclusion Criteria:

  • Were excluded subjects with changes in Mini-mental state examination (MMSE) scores by age and educational level where the minimum score represents: illiterate 13 points, less than 8 study years is 18 points, 8 or more study years is 26 points 11.
  • Were also excluded current smokers or previous, subjects with thrombosis, labyrinthitis, diabetes, hemodynamic instabilities, obesity, osteoporosis, neuromuscular diseases, pulmonary or cardiac diseases, changes in resting electrocardiogram or in exercise, ingestion of drugs to metabolism bone / muscle / heart chronotropism or with difficulties in adapting protocols
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    WBV and resistance

    used both interventions

    Device: WBV and Resistance

  • Experimental
    WBV & resistance sham

    used the vibrating platform and sham for resistance training

    Device: WBV & resistance sham

  • Experimental
    Resistance & sham WBV

    used resistance exercises and sham for vibrating platform

    Device: resistance & sham WBV

Interventions

  • DeviceWBV and Resistance

    use of WBV and resistance device during 03 months in elderly health people. The WBV used progressive increases of time and amplitude and the resistance training improves the weight. For Resistance: performed in upper and lower limbs in weight machine Mega II Movement®, used guidelines from American College of Sports Medicine for elderly, with two series of 08 repetitions (75% weight of one RM), considered for RM calculation the maximum voluntary isometric contraction. For WBV: used MY3 platform (Power Plate®, MY3, UK) frequency 35 hertz, tri-axial, amplitude 02 mm in adaptation and initial phases, increasing to 04 mm in phases intermediate and final. The time initial was 10 minutes, progressed to 15 min in second month, concluding with 20 min. Rest time between series remained 01 min.

  • Deviceresistance & sham WBV

    used only resistance For Resistance: performed in upper and lower limbs in weight machine Mega II Movement®, used guidelines from American College of Sports Medicine for elderly, with two series of 08 repetitions (75% weight of one RM), considered for RM calculation the maximum voluntary isometric contraction. For WBV: used MY3 platform (Power Plate®, MY3, UK)off.

  • DeviceWBV & resistance sham

    used really the WBV, but sham for resistance training For Resistance: performed similar movments in upper and lower limbs in weight machine Mega II Movement®, without using weights. For WBV: used MY3 platform (Power Plate®, MY3, UK) frequency 35 hertz, tri-axial, amplitude 02 mm in adaptation and initial phases, increasing to 04 mm in phases intermediate and final. The time initial was 10 minutes, progressed to 15 min in second month, concluding with 20 min. Rest time between series remained 01 min.

06

What researchers measure

Primary outcomes

  1. maximal O2 consumption

    Time frame: started and finished the protocol after 03 months

07

Study locations

1 site
  • UFPE
    Recife, Pernambuco 50740-560, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 10, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01681719
Lead sponsor
Maíra F Pessoa
Responsible party
Maíra F Pessoa (Principal Investigator, Universidade Federal de Pernambuco) — Sponsor-investigator
First posted
Sep 10, 2012
Start date
Jan 2011
Primary completion
Dec 2011
Last update
Sep 10, 2012

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion